Thus, multi-modality therapy involving cancer vaccines may be the key to the role of STAT3 inhibition in curative immunotherapy by promoting CD4 and CD8 T cell mediated tumor-specific killing [140]. This evidence concerns the gene STAT3 and neoplasm.